Answers are grounded in this paper and cite their sources.
DESIGN BLUEPRINT — SIMULATED, NOT MEASURED — NOT BUILT. Design blueprint derived from 'DNA Strand-Displacement Computing for Molecular Diagnostics: A Design Study of a Pancreatic Cancer Signature Classifier in a Drop of Blood' (DOI: 10.5281/zenodo.24108813). Specifies a single-use strand-displacement circuit in 50 uL of separated plasma at 37 C evaluating YES = (miR-21 AND miR-196a) AND (CA19-9 OR KRAS G12D) in three logical layers: 6 nt toeholds, net -6.9 kcal/mol per displacement, gates at 100 nM, thresholds at 30 nM, amplifier turnover and maximum fan-out 10, usable depth limit about 6 layers, worst-case classification time 12.8 minutes, signal-to-leak ratio 17.3 at depth 3, electronics about 1.3 x 10^11 times faster. The CA19-9 aptamer transducer is printed at full size as an UNVERIFIED load-bearing assumption. Includes circuit layering and signal-restoration sequence, quality-control and acceptance checks, failure modes, storage conditions, and explicit non-claims: nothing synthesised or tested, no clinical use, no diagnosis.
No takes yet. Share an insight, caveat, or question.
William Alexander Aldred (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: